Search research articles
Contact Us
Filters
Showing results (31-40 of 44) with videos related to
Page
of 5
Sort By:
Nature Communications
|
October 8, 2022
Hepatocyte phosphatase DUSP22 mitigates NASH-HCC progression by targeting FAK
Chenxu Ge, Jun Tan, Xianling Dai, et al.
Journal of Medicinal Chemistry
|
February 16, 2021
Correction to "<i>N</i>-(Pyrimidin-2-yl)-1,2,3,4-tetrahydroisoquinolin-6-amine Derivatives as Selective Janus Kinase 2 Inhibitors for the Treatment of Myeloproliferative Neoplasms"
Tao Yang, Mengshi Hu, Yong Chen, et al.
Journal of Medicinal Chemistry
|
November 1, 2019
Discovery of Potent and Orally Effective Dual Janus Kinase 2/FLT3 Inhibitors for the Treatment of Acute Myelogenous Leukemia and Myeloproliferative Neoplasms
Tao Yang, Mengshi Hu, Wenyan Qi, et al.
Journal of Medicinal Chemistry
|
January 28, 2020
Correction to "Discovery of Potent and Orally Effective Dual Janus Kinase 2/FLT3 Inhibitors for the Treatment of Acute Myelogenous Leukemia and Myeloproliferative Neoplasms"
Tao Yang, Mengshi Hu, Wenyan Qi, et al.
Journal of Medicinal Chemistry
|
December 1, 2020
<i>N</i>-(Pyrimidin-2-yl)-1,2,3,4-tetrahydroisoquinolin-6-amine Derivatives as Selective Janus Kinase 2 Inhibitors for the Treatment of Myeloproliferative Neoplasms
Tao Yang, Mengshi Hu, Yong Chen, et al.
Journal of Medicinal Chemistry
|
June 17, 2021
Discovery, Optimization, and Evaluation of Quinazolinone Derivatives with Novel Linkers as Orally Efficacious Phosphoinositide-3-Kinase Delta Inhibitors for Treatment of Inflammatory Diseases
Kongjun Liu, Dan Li, Wei Zheng, et al.
European Journal of Medicinal Chemistry
|
April 19, 2026
Structure-based design and synthesis of KX-01 analogs as potent antitumor agents targeting the tubulin colchicine binding site
Chufeng Zhang, Yilin Wang, Chenke Gao, et al.
Journal of Medicinal Chemistry
|
July 13, 2022
Discovery, Optimization, and Evaluation of Potent and Selective PI3Kδ-γ Dual Inhibitors for the Treatment of B-cell Malignancies
Kongjun Liu, Wei Zheng, Yong Chen, et al.
Bioorganic Chemistry
|
January 26, 2023
Design, synthesis and biological evaluation of purine-based derivatives as novel JAK2/BRD4(BD2) dual target inhibitors
Yong Guo, Yurong Zou, Yong Chen, et al.
Journal of Medicinal Chemistry
|
December 20, 2023
Discovery, Optimization, and Evaluation of Potent and Selective DNA-PK Inhibitors in Combination with Chemotherapy or Radiotherapy for the Treatment of Malignancies
Kongjun Liu, Xue Yuan, Tao Yang, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 44) with videos related to
Sort By:
Page
of 5
Nature Communications
|
October 8, 2022
Hepatocyte phosphatase DUSP22 mitigates NASH-HCC progression by targeting FAK
Chenxu Ge, Jun Tan, Xianling Dai, et al.
Journal of Medicinal Chemistry
|
February 16, 2021
Correction to "<i>N</i>-(Pyrimidin-2-yl)-1,2,3,4-tetrahydroisoquinolin-6-amine Derivatives as Selective Janus Kinase 2 Inhibitors for the Treatment of Myeloproliferative Neoplasms"
Tao Yang, Mengshi Hu, Yong Chen, et al.
Journal of Medicinal Chemistry
|
November 1, 2019
Discovery of Potent and Orally Effective Dual Janus Kinase 2/FLT3 Inhibitors for the Treatment of Acute Myelogenous Leukemia and Myeloproliferative Neoplasms
Tao Yang, Mengshi Hu, Wenyan Qi, et al.
Journal of Medicinal Chemistry
|
January 28, 2020
Correction to "Discovery of Potent and Orally Effective Dual Janus Kinase 2/FLT3 Inhibitors for the Treatment of Acute Myelogenous Leukemia and Myeloproliferative Neoplasms"
Tao Yang, Mengshi Hu, Wenyan Qi, et al.
Journal of Medicinal Chemistry
|
December 1, 2020
<i>N</i>-(Pyrimidin-2-yl)-1,2,3,4-tetrahydroisoquinolin-6-amine Derivatives as Selective Janus Kinase 2 Inhibitors for the Treatment of Myeloproliferative Neoplasms
Tao Yang, Mengshi Hu, Yong Chen, et al.
Journal of Medicinal Chemistry
|
June 17, 2021
Discovery, Optimization, and Evaluation of Quinazolinone Derivatives with Novel Linkers as Orally Efficacious Phosphoinositide-3-Kinase Delta Inhibitors for Treatment of Inflammatory Diseases
Kongjun Liu, Dan Li, Wei Zheng, et al.
European Journal of Medicinal Chemistry
|
April 19, 2026
Structure-based design and synthesis of KX-01 analogs as potent antitumor agents targeting the tubulin colchicine binding site
Chufeng Zhang, Yilin Wang, Chenke Gao, et al.
Journal of Medicinal Chemistry
|
July 13, 2022
Discovery, Optimization, and Evaluation of Potent and Selective PI3Kδ-γ Dual Inhibitors for the Treatment of B-cell Malignancies
Kongjun Liu, Wei Zheng, Yong Chen, et al.
Bioorganic Chemistry
|
January 26, 2023
Design, synthesis and biological evaluation of purine-based derivatives as novel JAK2/BRD4(BD2) dual target inhibitors
Yong Guo, Yurong Zou, Yong Chen, et al.
Journal of Medicinal Chemistry
|
December 20, 2023
Discovery, Optimization, and Evaluation of Potent and Selective DNA-PK Inhibitors in Combination with Chemotherapy or Radiotherapy for the Treatment of Malignancies
Kongjun Liu, Xue Yuan, Tao Yang, et al.
Page
of 5